ForDyne B.V. 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 08:46 am Sale |
2025-03-31 | 13G | Dyne Therapeutics, Inc. DYN |
ForDyne B.V. | 5,400,545 4.800% |
-394,819 (-6.81%) |
Filing |
| 2024-11-14 07:00 am Sale |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
ForDyne B.V. | 5,795,364 5.800% |
-335,715 (-5.48%) |
Filing |
| 2021-02-16 06:38 am Purchase |
2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
ForDyne B.V. | 6,131,079 13.490% |
6,131,079 (New Position) |
Filing |